CAS 728865-23-4 appears in our catalog under these names: CHIR–090, CHIR-090/ 96.1% (existing batch purity), CHIR-090 98+%, N-((2S,3R)-3-Hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl)-4-((4-(morpholinomethyl)phenyl)ethynyl)benzamide, 98+%, 98+%, CHIR-090, 99.20%. Offered by: GLPBio, TargetMol, Ambeed, Chemat, MedChemExpress. Available pack sizes: 1mg, 10mg, 25mg, 5mg, 10mM (in 1ml dmso), 50mg, 100mg, 500mg.
CHIR-090 is an L-threonine derivative obtained by formal condensation of the carboxy group of 4-({4-[(morpholin-4-yl)methyl]phenyl}ethynyl)benzoic acid with the amino group of N-hydroxy-L-threoninamide. It has a role as a lipopolysaccharide biosynthesis inhibitor, an EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor and an antimicrobial agent. It is a member of benzamides, a hydroxamic acid, a member of morpholines, an acetylenic compound and a L-threonine derivative.
Source: ChEBI
| Molecular formula | C24H27N3O5 |
|---|---|
| Molecular weight | 437.5 g/mol |
| IUPAC name | N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]benzamide |
| InChIKey | FQYBTYFKOHPWQT-VGSWGCGISA-N |
| SMILES | C[C@H]([C@@H](C(=O)NO)NC(=O)C1=CC=C(C=C1)C#CC2=CC=C(C=C2)CN3CCOCC3)O |
Computed by PubChem (NCBI)